Mirum Pharmaceuticals's total assets for Q4 2024 were $670.75M, an increase of 0.43% from the previous quarter. MIRM total liabilities were $445.11M for the fiscal quarter, a 2.12% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.